Don’t let Diabetes lead to heart problems.
The PROMINENT Study will include approximately 10,000 adults worldwide who have type 2 diabetes and elevated triglycerides. The main goal of the PROMINENT Study is to learn if a potential new medication (study drug) called pemafibrate can help prevent heart attacks and other heart-related conditions. It will also look at how safe the study drug is, and whether it can help reduce the level of triglycerides in blood.
If you join the study, you will continue taking your current statin medications (medications to lower “bad” cholesterol, also called LDL or low-density lipoprotein cholesterol).
Am I eligible to participate in the PROMINENT Study?
You may be able to take part in the PROMINENT Study if you:
- have a diagnosis of type 2 diabetes for 12 weeks or longer
- are a woman 55 years of age or more, a man 50 years of age or more, or are 18 years of age or more with systemic atherosclerosis (also called artery disease, which is a hardening or narrowing of the arteries)
- have been told you have moderately high triglyceride levels. Please ask your doctor if you are not sure.
At the first study center visit, the study team will check whether you are eligible for the study.
Triglycerides are a type of fat in your blood. If you take in more calories from food than your body needs, the body converts those calories into triglycerides. Triglycerides are stored in fat cells. High levels of triglycerides can increase your chances of having heart disease, especially in women.
What should I do next?
If you are interested in finding out more about the PROMINENT Study, the study team will be happy to answer any questions you may have. They can explain the potential risks and benefits of taking part. Please contact them using the details below.